NEW YORK (TheStreet) -- Core Laboratories (CLB) stock is dropping today after the oil and gas services provider reduced its second-quarter and full-year earnings and revenue guidance. By midmorning, shares had dropped 17.6% to $155.86.
The company expects net income for the quarter ending June between $1.32 and $1.35 a share and revenue of $265 million to $270 million. Analysts surveyed by Thomson Reuters expected earnings of $1.52 a share and revenue of $287.99 million.
For its full year, Core guides for earnings of $5.80 to $6 a share and revenue of $1.1 billion. Analysts forecast $6.20 a share and $1.16 billion in sales.
- CORE LABORATORIES NV has improved earnings per share by 10.7% in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past two years. We feel that this trend should continue. During the past fiscal year, CORE LABORATORIES NV increased its bottom line by earning $5.28 versus $4.55 in the prior year. This year, the market expects an improvement in earnings ($6.20 versus $5.28).
- Despite its growing revenue, the company underperformed as compared with the industry average of 10.6%. Since the same quarter one year prior, revenues slightly increased by 0.8%. Growth in the company's revenue appears to have helped boost the earnings per share.
- The company's current return on equity greatly increased when compared to its ROE from the same quarter one year prior. This is a signal of significant strength within the corporation. Compared to other companies in the Energy Equipment & Services industry and the overall market, CORE LABORATORIES NV's return on equity significantly exceeds that of both the industry average and the S&P 500.
- 38.51% is the gross profit margin for CORE LABORATORIES NV which we consider to be strong. It has increased from the same quarter the previous year. Along with this, the net profit margin of 23.22% significantly outperformed against the industry average.
- Investors have apparently begun to recognize positive factors similar to those we have mentioned in this report, including earnings growth. This has helped drive up the company's shares by a sharp 29.19% over the past year, a rise that has exceeded that of the S&P 500 Index. We feel that the stock's sharp appreciation over the last year has driven it to a price level which is now somewhat expensive compared to the rest of its industry. The other strengths this company shows, however, justify the higher price levels.
- You can view the full analysis from the report here: CLB Ratings Report
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts